Cordis Announces Acquisition of MedAlliance
By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.
Request Information
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
Monday – Friday 8 am – 5 pm
Florida / New York
Phone: 561.316.3330